Modeling of G-Protein Coupled Receptors with Bacteriorhodopsin as a Template. A Novel Approach Based on Interaction Energy Differences

References

• Schertler G. F. X., Villa C., Henderson R. Projection structure of rhodopsin. Nature 1993; 362: 770–772
   PubMed Web of Science ®Google Scholar
• Ovchinnikov Y. A. Rhodopsin and bacteriorhodopsin: structure‐function relationships. FEBS Lett. 1982; 148: 179–191
   PubMed Web of Science ®Google Scholar
• Fryxell K. J., Meyerowitz E. M. The Evolution of Rhodopsins and Neurotransmitter Receptors. J. Mol. Evol. 1991; 33: 367–378
   PubMedGoogle Scholar
• Henderson R., Baldwin J. M., Ceska T. A., Zemlin F., Beckmann E., Downing K. H. Model for the Structure of Bacteriorhodopsin Based on High‐resolution electron Cryo‐microscopy. J. Mol. Biol. 1990; 213: 899–929
   PubMed Web of Science ®Google Scholar
• Findlay J. B. C., Pappin D. J.C. The opsin family of proteins. Biochem. J. 1986; 238: 625–642
   PubMedGoogle Scholar
• Findlay J., Eliopoulos E. Three‐dimensional modeling of G protein‐linked receptors. Trends Pharmacol. Sci. 1990; 11: 492–499
   PubMed Web of Science ®Google Scholar
• Grötzinger J., Engels M., Jacoby E., Wollmer A., Straßburger W. A model for the C5a receptor and for its interaction with the ligand. Prot. Eng. 1991; 4: 767–771
   PubMedGoogle Scholar
• Höltje H. ‐D., Briem H. Molecular modeling studies in the mechanism of action of agonists and antagonists at G‐protein coupled membrane receptors. PharmacoChem. Libr. 1991; 16: 245–252
   Google Scholar
• Dahl S. G., Edvardsen Ø., Sylte I. Molecular dynamics of dopamine at the D2‐receptor. Proc. Natl. Acad. Sci. USA 1991; 88: 8111–8115
   PubMed Web of Science ®Google Scholar
• MaloneyHuss K., Lybrand T. P. Three‐dimensional structure for the ß2‐adrenergic receptor protein based on computer modeling studies. J. Mol. Biol. 1992; 225: 859–871
   PubMed Web of Science ®Google Scholar
• Baldwin J. M. The probable arrangement of the helices in G protein‐coupled receptors. EMBO J. 1993; 12: 1693–1703
   PubMed Web of Science ®Google Scholar
• Hibert M. F., Trumpp‐Kallmeyer S., Bruinvels A., Hoflack. Three‐dimensional Models of Neurotransmitter GTP‐Binding Protein‐Coupled Receptors. Mol. Pharmacol. 1991; 40: 8–15
   PubMed Web of Science ®Google Scholar
• Trumpp‐Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. Modeling of G‐protein‐coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992; 35: 3448–3462
   PubMed Web of Science ®Google Scholar
• Lewell W. Q. A model of the adrenergic beta‐2 receptor and binding sites for agonist and antagonist. Drug Design Discov. 1992; 9: 29–48
   PubMedGoogle Scholar
• Ijzerman A. P., van Galen P. J. M., Jacobson K. A. Molecular Modeling of Adenosine Receptors. I. The Ligand Binding Site on the Al‐Receptor. Drug Design Discov. 1992; 9: 49–67
   PubMedGoogle Scholar
• Nordvall G., Hacksell U. Binding‐Site Modeling of the Muscarinic m1‐Receptor: A Combination of Homology‐Based and Indirect Approaches. J. Med. Chem. 1993; 36: 967–976
   PubMedGoogle Scholar
• Brann M. R., Klimkowski V. J., Ellis J. Structure/Function Relationships of Muscarinic Acetylcholine Receptors. Life Sciences 1993; 52: 405–412
   PubMedGoogle Scholar
• Yamamoto Y., Kamiya K., Terao S. Modeling of Human Thromboxane A2‐Receptor and Analysis of the Receptor‐Ligand Interaction. J. Med. Chem. 1993; 36: 820–825
   PubMed Web of Science ®Google Scholar
• Cronet P., Sander C., Vriend G. Modeling of trans‐membrane seven helix bundles. Prot. Eng. 1993; 6: 59–64
   PubMedGoogle Scholar
• Hoflack J., Hibert M. F., Trumpp‐Kallmeyer S. Three‐dimensional models of Gonado‐Thyrotropin Hormone Receptor Transmembrane Domain. Drug Design Discov. 1993; 10: 157–171
   PubMedGoogle Scholar
• Donnelly D., Overington J. P., Ruffle S. V., Nugent J. H. A., Blundell T. L. Modeling α‐helical transmembrane domains: The calculation and use of substitution tables for lipid‐facing residues. Prot. Sci. 1993; 2: 55–70
   PubMed Web of Science ®Google Scholar
• Bowie J. U., Eisenberg D. Inverted protein structure prediction. Curr. Opin. struct. Biol. 1993; 3: 437–444
   Google Scholar
• Dunn R., McCoy J., Simsek M., Majumdar A., Chang S. H., Rajbhandary U. L., Khorana H. G. The bacteriorhodopsin gene. Proc. Natl. Acad. Sci. USA 1981; 78: 6744–6748
   PubMed Web of Science ®Google Scholar
• Probst W. C., Snyder L. A., Schuster D. I., Brosius J., Sealfon S. C. Sequence alignment of the G‐protein coupled receptor superfamily. DNA and Cell Biologie 1992; 11: 1–20
   PubMed Web of Science ®Google Scholar
• Henderson R., personal communication
   Google Scholar
• Greenhalgh D. A., Altenbach C., Hubbell W. L., Khorana H. G. Locations of Arg‐82, Asp‐85, and Asp‐96 in helix C of bacteriorhodopsin relative to the aqueous boundaries. Proc. Natl. Acad. Sci. USA 1991; 88: 8626–8630
   PubMedGoogle Scholar
• Popot J. ‐L., Gerchman S. ‐E., Engelman D. M. Refolding of bacteriorhodopsin in lipid bilayers. A thermodynamically controlled two‐stage process. J. Mol. Biol. 1987; 198: 655–676
   PubMedGoogle Scholar
• Popot J. ‐L., Engelman D. M. Membrane protein folding and oligomerization: the two‐stage model. Biochemistry 1990; 29: 4031–4037
   PubMed Web of Science ®Google Scholar
• Kahn T. W., Engelman D. M. Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five‐helix fragment. Biochemistry 1992; 31: 6144–6151
   PubMedGoogle Scholar
• Sharp K. A., Nicholls A., Friedman R., Honig B. Extracting hydrophobic free energies from experimental data: Relationship to protein folding and theoretical models. Biochemistry 1991; 30: 9686–9697
   PubMed Web of Science ®Google Scholar
• CHEMX. Chemical Design Ltd., OxfordEngland, developed and distributed by
   Google Scholar
• Vriend G. WHATIF: a molecular modeling and drug design program. J. Mol. Graph. 1990; 8: 52–56
   PubMed Web of Science ®Google Scholar
• , GROMOS program library (W.F. van Gunsteren program system GROMOS, distributed by BIOMOS biomolecular software b.v., Laboratory of Physical Chemistry, University of Groningen, NL)
   Google Scholar
• Kobilka B. K., Dixon R. A. F., Frielle T., Dohlman H. G., Bolanowski M. A., Sigal I. S., Yang‐Feng T. L., Franke U. A., Caron M. G., Lefkowitz R. J. cDNA for the human beta 2‐adrenergic receptor: a protein with multiple membrane‐spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet‐derived growth factor. Proc. Natl. Acad. Sci. USA 1987; 84: 46–50
   PubMed Web of Science ®Google Scholar
• Gerard N. P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991; 349: 614–617
   PubMed Web of Science ®Google Scholar
• Ovchinnikov Y. A., Abdulaev N. G., Feigina M. Y., Artamonov I. D., Zolotarev A. S., Kostina M. B., Bogachuck A. S., Moroshinikov A. I., Martinov V. I., Kudelin A. B. The complete amino acid sequence of visual rhodopsin. Bioorg. Khim. 1982; 8: 1011–1014
   Google Scholar
• Nathans J., Hogness D. S. Isolation sequence analysis, and intron‐exon arrangement of the gene encoding bovine rhodopsin. Cell 1983; 34: 807–814
   PubMed Web of Science ®Google Scholar
• Hargrave P. A., McDowell J. H., Curtis D. R., Wang J. K., Juszczak E., Fong S. ‐L., Rao J. K. M., Argos P. The structure of bovine rhodopsin. Biophys. Struct. Mechn. 1983; 9: 235–244
   PubMedGoogle Scholar
• Dixon R. A. F., Sigal I. S., Candelore M. R., Register R. B., Scattergood W., Rands E., Strader C. D. Structural features required for ligand binding to the beta‐adrenergic receptor. EMBO J. 1987; 6: 3269–3275
   PubMed Web of Science ®Google Scholar
• Dixon R. A. F., Sigal I. S., Strader C. D. Structure‐Function Analysis of the ß‐Adrenergic Receptor. Cold spring Harbor Symposia on Quantitative Biology 1988; LIII: 487–497
   Google Scholar
• Strader C. D., Sigal I. S., Register R. B., Candelore M. R., Rands E., Dixon R. A.F. Identification of residues required for ligand binding to the ß‐adrenergic receptor. Proc. Natl. Acad. Sci. USA 1987; 84: 4384–4388
   PubMed Web of Science ®Google Scholar
• Strader C. D., Sigal I. S., Candelore M. R., Rands E., Hill W. S., Dixon R. A.F. Conserved aspartic residues 79 and 113 of the ß‐adrenergic receptor have different roles in receptor function. J. Biol. Chem. 1988; 263: 10267–10271
   PubMed Web of Science ®Google Scholar
• Zhukovsky E. A., Oprian D. D. Effect of Carboxylic Acid Side Chains on the Absorption Maximum of Visual Pigments. Science 1989; 246: 928–930
   PubMedGoogle Scholar
• Franke R. R., Koenig B., Sakmar T. P., Khorana H. G., Hofmann K. P. Rhodopsin mutants that bind but fail to activate transducin. Science 1990; 250: 123–125
   PubMedGoogle Scholar
• Wess J., Nanavati S., Vogel Z., Maggio R. Functional role of proline and tryptophan residues highly conserved among G protein‐coupled receptors studied by mutational analysis of the m3‐muscarinic receptor. EMBO J. 1993; 12: 331–338
   PubMedGoogle Scholar
• Strader C. D., Candelore M. R., Hill W. S., Sigal I. S., Dixon R. A.F. Identification of two serine residues involved in agonist activation of the beta‐adrenergic receptor. J. Biol. Chem. 1989; 264: 13572–13578
   PubMedGoogle Scholar
• Fong T. M., Cascieri M. A., Yu H., Bansal A., Swain C., Strader C. D. Amino‐aromatic interaction between histidine 197 of the neurokinin‐1 receptor and CP 96345. Nature 1993; 362: 350–353
   PubMedGoogle Scholar
• Doi T., Molday R. S., Korana H. G. Role of the intra‐discal domain in rhodopsin assembly and function. Proc. Natl. Acad. Sci. USA 1990; 87: 4991–4995
   PubMed Web of Science ®Google Scholar
• Nathans J. Rhodopsin: Structure, Function and Genetics. Biochemistry 1992; 31: 4923–4931
   PubMed Web of Science ®Google Scholar
• Suryanarayana S., Daunt D. A., Von Zastrow M., Kobilka B. K. A Point Mutation in the seventh hydrophobic Domain of the α2‐Adrenergic Receptor Increases Its Affinity for a Family of ß‐Receptor Antagonists. J. Biol. Chem. 1991; 266: 15488–15492
   PubMed Web of Science ®Google Scholar
• Sachais B. S., Snider R. M., Lowe J. A., III, Krause J. E. Molecular Basis for the Species Selectivity of the Substance P Antagonist CP‐96, 345. J. Biol. Chem. 1993; 268: 2319–2323
   PubMed Web of Science ®Google Scholar
• Henderson R., Unwin P. N.T. Three‐dimensional model of purple membrane obtained by electron microscopy. Nature 1975; 257: 28–32
   PubMed Web of Science ®Google Scholar
• Mollison K. W., Mandecki W., Zuiderweg E. R. P., Fayer L., Fey T. A., Krause R. A., Conway R. G., Miller L., Edalji R. P., Shallcross M. A., Lane B., Fox J. L., Greer J., Carter G. W. Identification of receptor‐binding residues in the inflammatory complement protein C5a by site‐directed mutagenesis. Proc. Natl. Acad. Sci. USA 1989; 86: 292–296
   PubMedGoogle Scholar
• Bautsch W., Raffetseder U., unpublished data
   Google Scholar
• Cowan S. W., Schirmer T., Rummel G., Steiert M., Ghosh R., Pauptit R. A., Jansonius J. N., Rosenbusch J. P. Crystal structures explain functional properties of two E. coli porins. Nature 1992; 358: 727–733
   PubMed Web of Science ®Google Scholar
• Schiffer M., Chang C. ‐H., Stevens F. J. The functions of tryptophan residues in membrane proteins. Prot. Eng. 1992; 5: 213–214
   PubMedGoogle Scholar
• Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982; 157: 105–132
   PubMed Web of Science ®Google Scholar
• Allen J. P., Feher G., Yeates T. O., Komiya H., Rees D. C. Structure of the reaction center from Rhodobacter spaeroides R‐26: The protein subunits. Proc. Natl. Acad. Sci. USA 1987; 84: 6162–6166
   PubMed Web of Science ®Google Scholar
• Yeates T. O., Komiya H., Rees D. C., Allen J. P., Feher G. Structure of the reaction center from Rhodobacter sphaeroides R‐26: Membrane‐protein interactions. Proc. Natl. Acad. Sci. USA 1987; 84: 6438–6442
   PubMed Web of Science ®Google Scholar